News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-02-14 5:1:8 am IN8bio Announces Publication on Novel Gamma-Delta T Cell Therapy for Glioblastoma in Frontiers in Immunology GlobeNewsWire
2024-01-04 5:0:0 am IN8bio Highlights Recent Company Accomplishments and Outlines 2024 Pipeline Goals GlobeNewswire
2023-12-11 1:5:0 pm IN8bio Announces Positive Clinical Update Demonstrating Continued Durable Complete Remission in 100% of Evaluable Patients in Phase 1 Trial of INB-100 in Leukemia GlobeNewswire
2023-12-11 6:0:0 am IN8bio Announces Pricing of Financing Totaling up to $46.9 Million in Private Placement GlobeNewswire
2023-12-07 5:0:0 am IN8bio Appoints Dr. Corinne Epperly to Board of Directors GlobeNewswire
2023-12-05 5:0:0 am IN8bio to Host Investor Call at 8:30 AM ET on Tuesday, December 12 to Discuss Updated Clinical Data from Phase 1 Trial of INB-100 in Patients with Leukemia GlobeNewswire
2023-11-20 4:0:0 am IN8bio’s INB-200 Demonstrates Extended Progression-Free Survival in Patients with Newly Diagnosed Glioblastoma GlobeNewswire
   

Please consider a small donation if you think this website provides you with relevant information